Position in UTHR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$5,264,475
-$6,122,557 QoQ
Shares Held
8,878
-62.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026KBC Group NV holds $69,833,201 across 25 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
344,903 | $40,770,982 | |
| 2 | VTRS |
Viatris Inc
|
1,045,698 | $14,127,379 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
8,878 | $5,264,475 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
75,831 | $2,311,328 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
17,011 | $2,241,028 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
91,785 | $2,196,415 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
55,414 | $1,669,069 | |
| 8 | ALKS |
Alkermes plc.
|
5,106 | $180,548 |
All Filings in UTHR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,264,475 | 8,878 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $11,387,032 | 23,370 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $6,843,602 | 16,325 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $12,231,339 | 42,566 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $33,627,941 | 109,086 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $43,418,725 | 123,055 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $41,527,747 | 115,886 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $50,439,525 | 158,341 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $865,124 | 3,766 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $828,105 | 3,766 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $489,008 | 2,165 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $181,015 | 820 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $172,897 | 772 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $458,122 | 2,188 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $415,903 | 1,765 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $149,089 | 831 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $861,943 | 3,989 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $469,017 | 2,541 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $588,105 | 3,278 | Shares | Defined | 2022-02-15 | |
| 2020-12-31 | $2,337,717 | 15,401 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $554,793 | 5,493 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||